sinora 0.2 mg/ml solution for infusion
sintetica ireland limited - noradrenaline tartrate - solution for infusion - 0.2 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine
sinora 1 mg/ml concentrate for solution for infusion
sintetica ireland limited - noradrenaline tartrate - concentrate for solution for infusion - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine
novistig 0.5 mg/ml + 2.5 mg/ml solution for injection
sintetica ireland limited - glycopyrronium bromide; neostigmine metilsulfate - solution for injection - 0.5 mg/ml + 2.5 milligram(s)/millilitre - glycopyrronium bromide
novistig 0.5 mg/ml + 2.5 mg/ml solution for injection
sintetica gmbh - glycopyrronium bromide; neostigmine metilsulfate - solution for injection - glycopyrronium bromide
sinora 0.08 mg/ml solution for infusion
sintetica gmbh - norepinephrine bitartrate - solution for infusion - adrenergic and dopaminergic agents; norepinephrine
sinora 0.1 mg/ml solution for infusion
sintetica gmbh - noradrenaline tartrate - solution for infusion - adrenergic and dopaminergic agents; norepinephrine
sinora 0.16 mg/ml solution for infusion
sintetica gmbh - norepinephrine bitartrate - solution for infusion - adrenergic and dopaminergic agents; norepinephrine
sinora 0.2 mg/ml solution for infusion
sintetica gmbh - noradrenaline tartrate - solution for infusion - adrenergic and dopaminergic agents; norepinephrine
sinora 1 mg/ml concentrate for solution for infusion
sintetica gmbh - noradrenaline tartrate - concentrate for solution for infusion - adrenergic and dopaminergic agents; norepinephrine
na- lidocaine hydrochloride injection, solution
sintetica us llc - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.